ARCHIVES

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Couple Gives $1.1 Mil. To NCI Intramural Research; Kuller Replaces Grufferman At PCI

February 16, 1990

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012

In Brief: DCCR Advisory Committee Meeting Rescheduled; Durant To Head Cooperative Group Chairman

June 29, 1979

An Appreciation: Leonard Erickson, 1946–2013

June 7, 2013

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

Sharp To Direct New Institute For Brain Research At MIT.

March 3, 2000